Streetbeat News

Stock Prices

KORE

KORE Group Holdings projects its FY24 revenue to be between $300M-$305M, which is below the estimated $324.2M.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:05 am

KORE

Kore Group Holdings (NYSE:KORE) reported Q4 sales of $72.40M, missing the consensus estimate of $77.79M by 6.93%, but marking a 15.99% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 11:03 am

MU

Micron Technology, Inc. estimates that the recent earthquake will affect up to a mid-single digit percentage of a calendar quarter's company-level DRAM supply, as disclosed in their 8-K filing.

Portfolio Pulse from Charles Gross

April 11, 2024 | 10:53 am

KMX

CarMax (NYSE:KMX) reported Q4 earnings of $0.32 per share, missing the consensus estimate of $0.49, and sales of $5.63B, missing the $5.79B estimate. This represents a decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 10:52 am

VRTX

Evercore ISI Group analyst Liisa Bayko upgraded Vertex Pharmaceuticals (VRTX) from In-Line to Outperform with a new price target of $438.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 10:50 am

DIA

GLD

QQQ

SPY

USO

US stock markets fell after unexpectedly high inflation data, with the S&P 500, Dow Jones, and Nasdaq all closing lower. Inflation in the US rose to 3.5% in March, impacting global markets with mixed results in Asia and Europe. Commodities saw gold trading above $2,350, while crude oil prices dropped.

Portfolio Pulse from Akanksha Bakshi

April 11, 2024 | 10:47 am

CRMT

HCI

TRDA

Insiders at HCI Group, America's Car-Mart, and Entrada Therapeutics have made notable purchases of their company's stock, signaling confidence in their respective companies' futures. HCI Group's CEO acquired shares at an average price of $114.90, with an analyst maintaining an Outperform rating and a $140 price target. America's Car-Mart's CEO purchased shares at $61.62, despite an analyst maintaining an Underperform rating with a lowered price target. Entrada Therapeutics saw purchases by a director at an average price of $13.57, following upbeat quarterly sales.

Portfolio Pulse from Avi Kapoor

April 11, 2024 | 10:41 am

CLIA

CPYYY

SEMI

STM

STMicroelectronics N.V. (NYSE:STM) has signed a ten-year Power Purchase Agreement (PPA) with Centrica plc (OTC:CPYYY) to supply renewable energy to its Italian operations from January 2025. The deal involves approximately 61 GWh of renewable energy annually from a new solar farm in Italy, supporting STM's goal to become carbon neutral by 2027. This agreement follows a previous 15-year PPA with ERG for renewable energy supply. STM's Q1 2024 results will be announced on April 25, 2024. Investors can also engage with STM through ETFs like Veridien Climate Action ETF (NYSE:CLIA) and Columbia Seligman Semiconductor And Technology ETF (NYSE:SEMI). STM's stock saw a slight increase of 0.09% in premarket trading.

Portfolio Pulse from Lekha Gupta

April 11, 2024 | 10:41 am

SHOP

Piper Sandler analyst Clarke Jeffries maintains an Underweight rating on Shopify (NYSE:SHOP) with a $63 price target, indicating a bearish outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

April 11, 2024 | 10:38 am

C

Citigroup Inc. is expected to report lower Q1 earnings at $1.20 per share, down from $2.19 per share year-over-year, with revenue projected at $20.40 billion, up from $19.99 billion. The company announced a $2.75 billion redemption of notes due 2025. Shares fell 2.4% to $60.18. Analysts from Jefferies, Keefe, Bruyette & Woods, Wells Fargo, HSBC, and Oppenheimer have updated their ratings and price targets for Citigroup.

Portfolio Pulse from Avi Kapoor

April 11, 2024 | 10:31 am